Infection Control Market: Information by Type (Equipment, Services, Consumables), End-Use (Hospitals, Pharmaceutical Companies, Clinical Laboratories), and Region —Forecast till 2029

Feb 03, 2021   Infection control is important to prevent infectious diseases, primarily in hospitals and other healthcare facilities, home care, other public places to assure the sterility of that particular object/surface. This market covers various products and services used for the purpose of sterilizing, disinfecting, and cleaning the healthcare settings. In addition to this, the unparalleled amount of devastation caused by the Covid-19 pandemic around the globe has contributed to higher demand for infecti...
Request Free Sample Report

Report Description

Infection control is important to prevent infectious diseases, primarily in hospitals and other healthcare facilities, home care, other public places to assure the sterility of that particular object/surface. This market covers various products and services used for the purpose of sterilizing, disinfecting, and cleaning the healthcare settings. In addition to this, the unparalleled amount of devastation caused by the Covid-19 pandemic around the globe has contributed to higher demand for infection control products and services.

Infection control is important to prevent infectious diseases, primarily in hospitals and other healthcare facilities, home care, other public places to assure the sterility of that particular object/surface. This market covers various products and services used to sterilize, disinfect, and clean in healthcare settings. Besides, the unparalleled amounts of the devastation caused by the Covid-19 pandemic have contributed to higher demand for infection control products and services.

In January 2020, in nine governorates of the Egypt region, the Ministry of Health and Population launched the second phase of the Infection Control Initiative. This kind of support from various government and non-government organizations for the prevention of infection is anticipated to have a significant impact on infection control products. Furthermore, the World Health Organization (WHO) has addresses guidelines for disinfection, sterilization for control of pandemic and epidemic-prone acute respiratory infections in healthcare to promote awareness regarding high-end infection prevention measures worldwide.

Factors such as rising hospital-acquired infections (HAIs), growing prevalence of chronic diseases, technological advancements, accelerating geriatric population, and upward demand for outsourcing of sterilization services globally are driving the market growth for the infection control treatment. However, stringent regulatory requirements and safety concerns associated with reprocessed instruments for this condition are expected to restrain the market growth during the forecast period.

The global infection control market was estimated at USD 19970 million in 2019 and is expected to grow at 6.9% CAGR during the forecast study period.

Infection-Control-Market

Market Drivers

Rise in Prevalence of Hospital-Acquired Infections (HAIs)

HAIs are a nosocomial infection, which arises during a patient's stay at hospitals and other associated facilities and is undetected at the time of admission. These types of diseases include central line-related bloodstream, surgical site, and urinary tract infections associated with catheters, hospital-acquired pneumonia, ventilator-associated pneumonia, and infections associated with Clostridium difficile.

According to a research article published in the British Medical Journal, in 2016-2017, there were about 6,53,000 healthcare-associated infections (HCAIs) reported among the 13.8 million adult inpatients in NHS hospitals in England. Of these, around 22800 patients died due to infection. It also stated that there were approximately 13,900 HCAIs of a total of 8,10,000 frontline HCPs. The incidence of HAIs depends primarily on the patients’ immunity, infection prevention practices, and the presence of different infectious agents in the health care facility, leading to an upsurge in demand for infection control products and services. 

This is expected to enhance market growth during the forecast period. 

Infection-Control-Market-Growth

Growing Demand for Outsourcing of Sterilization Services

In countries like the U.S. and few Western Europe, healthcare facilities are increasingly outsourcing the Central Sterile Supply Department (CSSD) functions to meet infection control standards and top-quality management of complex surgical instruments.

Several experts suggest that the third-party sterilization vendors will increase their focus on becoming end-to-end solution providers to cover cleaning, sterilization, tracking and managing workflow, CSSD layout design, and logistics services. This will drive original equipment manufacturers (OEMs) to embrace value-added services, including inventory management, CSSD integration, and equipment repair, in their portfolio over the traditional product-centered approach. This step would ensure third-party sterilization services in direct contact with key decision-makers for better infection control by opening market expanding avenues. 

The growth in such outsourcing trends among pharma companies, medical device manufacturers, and hospitals is anticipated to drive the overall market growth. 

Market Segmentation

Consumables to Dominate the Type Segment

The consumables segment held the largest market share in 2019. This segment is further segmented into infectious waste disposal, disinfectants, sterilization consumables, personal protective equipment, and others.

This segment is anticipated to maintain its supremacy over the projected period, primarily due to its extensive use in disinfection, sterilization, and other infection control procedures. The largest share captured by consumables is expected to be a consequence of consistent usage along with a short life cycle of these products. In addition to this, personal protective equipment dominated the consumables segment. This is attributed to growing awareness by different healthcare associations regarding benefits associated with personal protective equipment.

Hospitals Held Largest Share by End-Use

The hospital segment is accounted for the largest share of the global infection control market in 2019. This is majorly due to the growing adoption of newer and innovative infection control treatment solutions and the probability of acquiring infections in the hospital area. The adoption of a highly efficient infection control system in hospital premises is predominantly due to HAIs that require stringent control. The overall hospital-acquired infections, including ventilator-associated pneumonia, catheter-associated urinary tract infections, and catheter-related bloodstreams are expected to positively influence the adoption of infection prevention measures.

Regional Overview

North-America-Lead-Infection-Control-Market

The regional analysis has been made considering the trends of the infection control market, in the regions of North America, Europe, Asia-Pacific, Central, and South America and the Caribbean, and the Middle East and Africa.

The Americas Dominated the Global Infection Control Market

The American regional market held a significant market share to itself during the forecast period and is expected to grow at a high CAGR. Further, at the country level, the U.S. is expected to generate high revenue. The strong regional market can be attributed to the increasing incidence of HAIs. For instance, in the U.S., hospital-acquired urinary tract infections (UTIs), frequently occurring HAIs account for up to 40% each year, as per the National Nosocomial Infection Surveillance (NNIS) system report.

Growing efforts by key market players to launch new products and expand their geographical presence globally is driving the market for the North American region. For instance, Advanced Sterilization Products launched the STERRAD 100NX System in the U.S. in January 2017 and is planning to widen its presence in Europe, the Middle East and Africa.

Asia-Pacific Anticipated to Show Promising Growth during the Forecast Period

Asia-Pacific infection control market is expected to witness the highest CAGR during the forecast period due to the rise in inpatient population, growing awareness about improving quality hospital care, accelerated cost of HAIs, and government initiatives. Moreover, an increase in the number of medical device and pharma industries in emerging economies, such as China, India, Brazil, and countries in Southeast Asia is anticipated to offer immense opportunities for market growth in this region. 

Key Players

  • 3M Company
  • Belimed AG
  • Halyard Health, Inc.
  • Getinge Group
  • Advanced Sterilization Products
  • Matchana Group
  • Sterigenics International
  • MMM Group
  • Cantel Medical Corporation
  • STERUS Corporation

Recent Developments

  • In December 2018, Ecolab (US) acquired Holchem Group Limited (UK) to strengthen the hygiene and cleaning product portfolio.
  • In April 2018, MMM Group announced a partnership with ITS Science & Medical to expand its distribution network in Indonesia.

Infection Control Market Segmentation

By Type

  • Equipment
  • Disinfectors
    • Washers
    • Flushers
    • Endoscope Reprocessors
  • Sterilization equipment
    • Heat Sterilization Equipment
    • Low-Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
    • Filtration Sterilization Equipment
    • Liquid Sterilization Equipment
  • Others

By Services

  • Contract Sterilization
    • Ethylene Oxide Sterilization
    • E-beam Sterilization
    • Gamma Sterilization
    • Others
  • Infectious Waste Disposal

By Consumables

  • Infectious Waste Disposal
  • Disinfectants
  • Sterilization Consumables
  • Personal Protective Equipment
  • Others

By End-Use

  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • Central and South America and the Caribbean
  • The Middle-East and Africa

Frequently Asked Questions (FAQs)

Hospitals Segment is expected to be the leading segment in Infection Control Market during the forecast period.
In 2019 Global Infection Control Market was valued at USD 19970 million.
3M Company, Belimed AG, Halyard Health, Inc., Getinge Group, Advanced Sterilization Products, Matchana Group, Sterigenics International, MMM Group, Cantel Medical Corporation, STERUS Corporation are the top players in Infection Control Market.
North America is expected to hold the highest market share in Infection Control Market.
Rising hospital-acquired infections, growing prevalence of chronic diseases, technological advancements, accelerating geriatric population, and upward demand for outsourcing of sterilization services globally are the key factors expected to drive Infection Control Market during the forecast period.
The global infection control market was estimated at USD 19970 million in 2019 and is expected to grow at 6.9% CAGR during the forecast study period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically, choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

Infection control is important to prevent infectious diseases, primarily in hospitals and other healthcare facilities, home care, other public places to assure the sterility of that particular object/surface. This market covers various products and services used for the purpose of sterilizing, disinfecting, and cleaning the healthcare settings. In addition to this, the unparalleled amount of devastation caused by the Covid-19 pandemic around the globe has contributed to higher demand for infection control products and services.

Infection control is important to prevent infectious diseases, primarily in hospitals and other healthcare facilities, home care, other public places to assure the sterility of that particular object/surface. This market covers various products and services used to sterilize, disinfect, and clean in healthcare settings. Besides, the unparalleled amounts of the devastation caused by the Covid-19 pandemic have contributed to higher demand for infection control products and services.

In January 2020, in nine governorates of the Egypt region, the Ministry of Health and Population launched the second phase of the Infection Control Initiative. This kind of support from various government and non-government organizations for the prevention of infection is anticipated to have a significant impact on infection control products. Furthermore, the World Health Organization (WHO) has addresses guidelines for disinfection, sterilization for control of pandemic and epidemic-prone acute respiratory infections in healthcare to promote awareness regarding high-end infection prevention measures worldwide.

Factors such as rising hospital-acquired infections (HAIs), growing prevalence of chronic diseases, technological advancements, accelerating geriatric population, and upward demand for outsourcing of sterilization services globally are driving the market growth for the infection control treatment. However, stringent regulatory requirements and safety concerns associated with reprocessed instruments for this condition are expected to restrain the market growth during the forecast period.

The global infection control market was estimated at USD 19970 million in 2019 and is expected to grow at 6.9% CAGR during the forecast study period.

Infection-Control-Market

Market Drivers

Rise in Prevalence of Hospital-Acquired Infections (HAIs)

HAIs are a nosocomial infection, which arises during a patient's stay at hospitals and other associated facilities and is undetected at the time of admission. These types of diseases include central line-related bloodstream, surgical site, and urinary tract infections associated with catheters, hospital-acquired pneumonia, ventilator-associated pneumonia, and infections associated with Clostridium difficile.

According to a research article published in the British Medical Journal, in 2016-2017, there were about 6,53,000 healthcare-associated infections (HCAIs) reported among the 13.8 million adult inpatients in NHS hospitals in England. Of these, around 22800 patients died due to infection. It also stated that there were approximately 13,900 HCAIs of a total of 8,10,000 frontline HCPs. The incidence of HAIs depends primarily on the patients’ immunity, infection prevention practices, and the presence of different infectious agents in the health care facility, leading to an upsurge in demand for infection control products and services. 

This is expected to enhance market growth during the forecast period. 

Infection-Control-Market-Growth

Growing Demand for Outsourcing of Sterilization Services

In countries like the U.S. and few Western Europe, healthcare facilities are increasingly outsourcing the Central Sterile Supply Department (CSSD) functions to meet infection control standards and top-quality management of complex surgical instruments.

Several experts suggest that the third-party sterilization vendors will increase their focus on becoming end-to-end solution providers to cover cleaning, sterilization, tracking and managing workflow, CSSD layout design, and logistics services. This will drive original equipment manufacturers (OEMs) to embrace value-added services, including inventory management, CSSD integration, and equipment repair, in their portfolio over the traditional product-centered approach. This step would ensure third-party sterilization services in direct contact with key decision-makers for better infection control by opening market expanding avenues. 

The growth in such outsourcing trends among pharma companies, medical device manufacturers, and hospitals is anticipated to drive the overall market growth. 

Market Segmentation

Consumables to Dominate the Type Segment

The consumables segment held the largest market share in 2019. This segment is further segmented into infectious waste disposal, disinfectants, sterilization consumables, personal protective equipment, and others.

This segment is anticipated to maintain its supremacy over the projected period, primarily due to its extensive use in disinfection, sterilization, and other infection control procedures. The largest share captured by consumables is expected to be a consequence of consistent usage along with a short life cycle of these products. In addition to this, personal protective equipment dominated the consumables segment. This is attributed to growing awareness by different healthcare associations regarding benefits associated with personal protective equipment.

Hospitals Held Largest Share by End-Use

The hospital segment is accounted for the largest share of the global infection control market in 2019. This is majorly due to the growing adoption of newer and innovative infection control treatment solutions and the probability of acquiring infections in the hospital area. The adoption of a highly efficient infection control system in hospital premises is predominantly due to HAIs that require stringent control. The overall hospital-acquired infections, including ventilator-associated pneumonia, catheter-associated urinary tract infections, and catheter-related bloodstreams are expected to positively influence the adoption of infection prevention measures.

Regional Overview

North-America-Lead-Infection-Control-Market

The regional analysis has been made considering the trends of the infection control market, in the regions of North America, Europe, Asia-Pacific, Central, and South America and the Caribbean, and the Middle East and Africa.

The Americas Dominated the Global Infection Control Market

The American regional market held a significant market share to itself during the forecast period and is expected to grow at a high CAGR. Further, at the country level, the U.S. is expected to generate high revenue. The strong regional market can be attributed to the increasing incidence of HAIs. For instance, in the U.S., hospital-acquired urinary tract infections (UTIs), frequently occurring HAIs account for up to 40% each year, as per the National Nosocomial Infection Surveillance (NNIS) system report.

Growing efforts by key market players to launch new products and expand their geographical presence globally is driving the market for the North American region. For instance, Advanced Sterilization Products launched the STERRAD 100NX System in the U.S. in January 2017 and is planning to widen its presence in Europe, the Middle East and Africa.

Asia-Pacific Anticipated to Show Promising Growth during the Forecast Period

Asia-Pacific infection control market is expected to witness the highest CAGR during the forecast period due to the rise in inpatient population, growing awareness about improving quality hospital care, accelerated cost of HAIs, and government initiatives. Moreover, an increase in the number of medical device and pharma industries in emerging economies, such as China, India, Brazil, and countries in Southeast Asia is anticipated to offer immense opportunities for market growth in this region. 

Key Players

  • 3M Company
  • Belimed AG
  • Halyard Health, Inc.
  • Getinge Group
  • Advanced Sterilization Products
  • Matchana Group
  • Sterigenics International
  • MMM Group
  • Cantel Medical Corporation
  • STERUS Corporation

Recent Developments

  • In December 2018, Ecolab (US) acquired Holchem Group Limited (UK) to strengthen the hygiene and cleaning product portfolio.
  • In April 2018, MMM Group announced a partnership with ITS Science & Medical to expand its distribution network in Indonesia.

Infection Control Market Segmentation

By Type

  • Equipment
  • Disinfectors
    • Washers
    • Flushers
    • Endoscope Reprocessors
  • Sterilization equipment
    • Heat Sterilization Equipment
    • Low-Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
    • Filtration Sterilization Equipment
    • Liquid Sterilization Equipment
  • Others

By Services

  • Contract Sterilization
    • Ethylene Oxide Sterilization
    • E-beam Sterilization
    • Gamma Sterilization
    • Others
  • Infectious Waste Disposal

By Consumables

  • Infectious Waste Disposal
  • Disinfectants
  • Sterilization Consumables
  • Personal Protective Equipment
  • Others

By End-Use

  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • Central and South America and the Caribbean
  • The Middle-East and Africa

Frequently Asked Questions (FAQs)

Hospitals Segment is expected to be the leading segment in Infection Control Market during the forecast period.
In 2019 Global Infection Control Market was valued at USD 19970 million.
3M Company, Belimed AG, Halyard Health, Inc., Getinge Group, Advanced Sterilization Products, Matchana Group, Sterigenics International, MMM Group, Cantel Medical Corporation, STERUS Corporation are the top players in Infection Control Market.
North America is expected to hold the highest market share in Infection Control Market.
Rising hospital-acquired infections, growing prevalence of chronic diseases, technological advancements, accelerating geriatric population, and upward demand for outsourcing of sterilization services globally are the key factors expected to drive Infection Control Market during the forecast period.
The global infection control market was estimated at USD 19970 million in 2019 and is expected to grow at 6.9% CAGR during the forecast study period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically, choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.